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Abstract
Introduction: Coxiella burnetii, the causative agent of Q fever, may cause endocarditis and vascular infections that
result in severe morbidity and mortality. We report a case of a C. burnetii-infected abdominal aorta and its
management in a patient with a previous endovascular aortic aneurysm repair.
Case presentation: A 62-year-old Caucasian man was admitted to our hospital three months after endovascular
aortic aneurysm repair with a bifurcated stent graft. He had increasing abdominal complaints and general malaise.
A computed tomography scan of his abdomen revealed several para-aneurysmal abscesses. Surgery was performed
via midline laparotomy. The entire abdominal wall of his aneurysmal sac, including the abscesses, was removed.
The vascular endoprosthesis showed no macroscopic signs of infection. The decision was made to leave the
endograft in place because of the severe cardiopulmonary comorbidities, thereby avoiding suprarenal clamping
and explantation of this device with venous reconstruction. The proximal and distal parts of the endograft were
secured to the aortic wall and common iliac artery walls, respectively, to avoid future migration. Polymerase chain
reaction for C. burnetii was positive in all specimens of aortic tissue. Specific antibiotic therapy was initiated. Our
patient was discharged in good clinical condition after six days.
Conclusions: In our patient, the infection was limited to the abdominal aneurysm wall, which was removed,
leaving the endograft in place. Vascular surgeons should be familiar with this bailout procedure in high-risk
patients.
Introduction
Coxiella burnetii, the causative organism of Q fever, is
increasingly reported to be associated with infections of
abdominal aortic aneurysms and vascular grafts. C. bur-
netii is a small obligate intracellular Gram-negative bac-
terium related to the Rickettsiaceae family. Cattle, sheep,
and goats are the primary reservoirs. Infection of
humans usually occurs by inhalation of these organisms
from air containing contaminated airborne barnyard
dust. Symptoms of Q fever are polymorphic and non-
specific and disease occurs in two stages: an acute stage
that may present with headaches, chills, and respiratory
symptoms and an insidious chronic stage. Acute Q fever
is usually mild and recovery is spontaneous. However,
C. burnetii is able to persist in host macrophages despite
apparent cure, leaving patients, especially those with
heart valve pathology or vascular defects, at risk of
developing a chronic infection. Endocarditis is the main
form of chronic Q fever (60% to 70% of all cases), fol-
lowed by infections of aneurysms and vascular pros-
theses (9%) [1]. Multiple reports of cases of C. burnetii
vascular infections have been published; overall mortal-
ity, most often due to vascular rupture, is 25% [2].
Given the significant morbidity and mortality of an
infected aortic aneurysm or vascular endoprosthesis and
the importance of targeted and prolonged antibiotic
therapy besides surgery, the diagnosis of C. burnetii
infection is crucial to a successful therapeutic outcome.
We report a case of a C. burnetii-infected abdominal
aorta in a patient with a previous endovascular aortic
aneurysm repair.
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A 62-year-old Caucasian man had a history of general
malaise and recurrent fever. His general practitioner
commissioned seven days of doxycycline therapy under
the suspicion of Q fever, although the results of serologi-
cal testing were negative. The patient still complained of
general malaise and experienced progressive abdominal
pain based on a symptomatic infrarenal aortic aneurysm
of more than 6 cm, which was treated electively with an
endovascular repair at another hospital. A bifurcated
endograft was implanted without complications. The
patient experienced a short episode of high fever early
after the operation but remained free of symptoms for
three months when he was readmitted to the hospital
with increasing abdominal complaints and general
malaise. On admission, he was afebrile. The results of a
clinical examination were normal except for abdominal
tenderness on deep palpation. Blood cultures were sterile
in the absence of any recent antibiotic therapy. Labora-
tory results showed a white blood cell count of 11.5 ×
10
9/L and a C-reactive protein level of 24 mg/L. A sero-
logical test showed the persistence of C. burnetii phase II
antibodies (immunoglobulin G [IgG]: 4096) and the
appearance of phase I antibodies (IgG: 2048). A com-
puted tomography (CT) scan of the abdomen revealed
several para-aneurysmal fluid collections (Figure 1a).
At that point, the patient was referred to our hospital
for surgical treatment of his infected abdominal aortic
aneurysm. Surgery was performed via midline laparot-
omy. A visual inspection showed huge abscesses in his
abdominal aortic wall. The entire abdominal wall of his
aneurysmal sac, including the abscesses, was removed.
Figure 1 (a) Para-aortic abscesses (arrow). (b,c) Peri-operative view of infected aneurysm wall (arrow). (d) A four-week post-operative
computer tomography scan shows no abscesses.
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signs of infection, and because of the severe cardiopul-
monary comorbidities, the decision was made to leave
the endograft in place to avoid suprarenal clamping and
explantation of this device with venous reconstruction.
The proximal part and distal parts of the endograft were
secured (with stitches) to the aortic wall and common
iliac artery walls, respectively, to avoid future migration.
The overlap zones of the endograft components were
also secured with stitches. After that, the endograft was
wrapped with omentum (Figure 1b,c). Blood, thrombus,
and tissue cultures remained sterile, but polymerase
chain reaction for C. burnetii was positive in all speci-
mens, and specific staining of the aneurysmal sac for C.
burnetii microorganisms was negative. Specific antibiotic
therapy with Ciproxin (ciprofloxacin) 1500 mg/day and
doxycycline 200 mg/day was initiated. Our patient was
discharged in good clinical condition after six days.
Three months after surgery, he was readmitted to our
hospital with subfebrile temperature, abdominal discom-
fort, nausea, incidental vomiting, and diarrhea. Blood
cultures, transesophageal echocardiography, CT scans,
and positron emission tomography scans were per-
formed. The results of all of these measures were nega-
tive for reoccurrence of Q fever or infection of the
endoprosthesis. Serological tests revealed no reoccur-
rence or persistence of C. burnetii infection. Antibiotic
therapy on admittance included hydroxychloroquine,
which is known to cause gastric complaints and general
malaise. Our patient’s complaints diminished after this
was stopped and Ciproxin was restarted.
Six months after the first readmission, our patient was
readmitted with cyanotic and painful toes to our hospi-
tal. Magnetic resonance imaging showed a functional
endoprosthesis with no signs of stenosis or endoleak.
Limited cutaneous systemic sclerosis in the absence of
signs of macrovascular pathology was diagnosed. He was
successfully treated with iloprost intravenously for 14
days, and an angiotensin-converting enzyme inhibitor
and calcium antagonist were added to his medication.
Our patient remained free of symptoms with unchanged
and normal aspect of the endograft without signs of
abscesses or infection, as seen on a CT scan (Figure 1d).
Discussion
C. burnetii is the etiologic agent of Q fever, a zoonosis
with a worldwide distribution in rural and, more
recently, urban areas. Infection of humans usually
occurs by inhalation of these organisms from air that
contains airborne barnyard dust contaminated by dried
placental material, birth fluids, and excreta of infected
herd animals. Ingestion of contaminated milk, followed
by regurgitation and inspiration of the contaminated
food, is a less common mode of transmission. Our
patient lived in an endemic region but had no known
exposure to C burnetii.
Only about one half of all people infected with C. bur-
netii show signs of clinical illness. Acute cases of Q
fever begin with a sudden onset of one or more of the
following complaints: high fever (up to 104°F to 105°F),
severe headache, general malaise, myalgia, confusion,
sore throat, chills, sweats, non-productive cough, nausea,
vomiting, diarrhea, abdominal pain, and chest pain.
Fever usually lasts for one to two weeks. Weight loss
can occur and persist for some time. Thirty to fifty per-
cent of patients with a symptomatic infection will
develop pneumonia. Additionally, a majority of patients
have abnormal results on liver function tests and some
will develop hepatitis. In general, most patients will
recover, but 1% to 2% of infected people with acute Q
fever die.
Chronic Q fever, characterized by infection that per-
sists for more than six months, is uncommon but
potentially lethal. Patients who have had acute Q fever
may develop the chronic form within one to 20 years
after initial infection. Endocarditis with negative blood
cultures, the most frequent clinical presentation of
chronic Q fever, accounts for 60% to 70% of the cases;
next in frequency is vascular infection, which accounts
for 8% of the cases [3]. Pre-existing cardiovascular dis-
ease may facilitate passage from acute to chronic Q
fever despite antibiotic therapy. C. Burnetii as an obli-
gate intracellular bacterium is able to persist in mono-
c y t e sa n dm a c r o p h a g e st h a ta r ep r e s e n ti na o r t i c
thrombus and damaged cardiac valves [4]. Transplant
recipients, patients with cancer, and those with chronic
kidney disease are also at risk of developing chronic Q
fever. As many as 65% of patients with chronic Q fever
may die of the disease.
Here, we report a case of C. burnetii infection of the
wall of an abdominal aortic aneurysm in a patient with
a previous endovascular aortic aneurysm repair. This
unexpected diagnosis was made on the basis of serology
and polymerase chain reaction on aspired fluid from an
abdominal abscess. Recently, a report describing percu-
taneous management of a C. Burnetii-induced paraver-
tebral abscess after emergency placement of an
endograft was published [5]. C. burnetii aortic aneurysm
infections are sometimes challenging to diagnose and
treat. The cornerstone of treatment of aneurysms or
infected vascular grafts is usually surgical excision in
addition to antibiotic treatment [2]. Vascular reconstruc-
tion may include graft replacement or extra-anatomic
bypass, which has a mortality rate of up to 33% in this
patient group [6]. Alternatively, vascular reconstruction
using autologus aortoiliac to femoral artery reconstruc-
tion with deep femoral-popliteal or superficial spiral
saphenous veins can be performed. These procedures
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ent morbidities such as compartment syndrome, deep
venous thrombosis, and chronic limb swelling and a
mortality risk of 7% to 15% [7,8]. In our patient, the
abdominal aortic aneurysm wall itself, and not the endo-
graft, was macroscopically infected. To avoid suprarenal
clamping, explantation of the endograft, and complex
reconstructive surgery, we chose to leave the endograft
in situ. It is very important to secure the proximal and
distal sealing zones to the native arteries as well as the
endograft components to avoid endoleaks or migration
during follow-up. Owing to the resection of the aneur-
ysm wall, every type of endoleak will lead to life-threa-
tening hemorrhages.
The diagnostic key is clinical awareness with a high
index of suspicion. Q fever can be diagnosed serologi-
cally by high levels of specific antibodies to C. burnetii,
immunohistology demonstrating C. burnetii within the
cytoplasma of macrophages, or polymerase chain reac-
tion-based methods. Cell culture isolation is not widely
available as a diagnostic technique, as it requires a bio-
safety level 3 laboratory. Positive serology for C. burnetii
is determined by the presence of phase I and II antibody
titers. Acute Q fever is characterized by a predominance
of phase II antibodies (more than 200), whereas chronic
Q fever is associated with high levels of phase I antibo-
dies (greater than or equal to phase II titers) [3].
There are no specific guidelines for Q fever vascular
prosthesis infections; experience has been derived from
the treatment of Q fever endocarditis. Oral antibiotic
regimens include doxycycline and hydroxychloroquine
or doxycycline and a quinolone. The duration of anti-
biotic treatment is best targeted on serological monitor-
ing of phase I antibody titers. A decrease of phase I IgG
and IgA antibody titers to below 200 is a criterion for
clinical cure. Serological evaluation is recommended
monthly for the first six months after antibiotics are dis-
continued and every three months for two years before
the patient can be considered cured [9].
Conclusions
Chronic C. burnetii aortic abdominal wall infection is a
life-threatening disease with devastating complications
and a poor prognosis. In our patient, the infection was
limited to the abdominal aneurysm wall and the endo-
graft could be left in place. Vascular surgeons should be
familiar with this bailout procedure in high-risk patients.
The first episode of Q fever may remain asymptomatic,
making an early and accurate diagnosis fairly difficult.
We recommend systematic serological testing for C.
burnetii in all patients with the combination of possible
exposure, an abdominal aortic aneurysm and unex-
plained fever, abdominal pain, or weight loss.
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